
ACCESSWIRE
@accesswire
News network reaching more than 1,500 media outlets in 98 countries. The newest, fastest-growing and most disruptive newswire available today.
ID: 192256693
http://www.accesswire.com 18-09-2010 16:34:14
66,66K Tweet
2,2K Followers
2,2K Following


Petros Pharmaceuticals’ (Petros Pharmaceuticals) STENDRA(R) (avanafil) Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance ow.ly/O2Zu50SCile

Idaho Strategic (Idaho Strategic Resources) to Present at the MicroCap Leadership Summit and Provide Attendees with a Tour of the Golden Chest Mine ow.ly/3IjL50SI44I



Petros Pharmaceuticals' (Petros Pharmaceuticals) Pivotal Statistically Significant Self Selection Study Shows Stronger Results with Proprietary Technology Application as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil) ow.ly/f93650SMn8Q


Aytu BioPharma (Aytu_BioPharma) Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations ow.ly/P7Eo50SS3i4


Idaho Strategic (Idaho Strategic Resources) Receives Grant Funding to Support Power Infrastructure Upgrades to the Golden Chest Mine ow.ly/6yXq50SU9nL


Aytu BioPharma (Aytu_BioPharma) to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024 ow.ly/I0lm50SUP9h

Full Alliance Group, Inc. (Full Alliance Group) (OTC: FAGI) Wholly Owned Subsidiary Dynamaxx Health Inc. Secures Its Own Manufacturing Contract for Medical Devices for MAXX Health Clinics ow.ly/l0Og50SXK09

AYRO (AYRO, Inc.) Appoints New Management Team to Re-Engineer and Revamp a Lower Cost Low-Speed Electric Vehicle ow.ly/QQsU50T352Q


Petros Pharmaceuticals (Petros Pharmaceuticals) Executes Successful Initial Test for App Comprehension as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil) ow.ly/JSeA50Tl5gP

Aytu BioPharma (Aytu_BioPharma) to Report Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results on September 26, 2024 ow.ly/EfNF50Trnw6


